Ledger.Open graph →
SEC Form D · filed August 22, 2022

Innervace, Inc

Offering
$40.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David Greenwald · New York, NYDirectorNader Halim · New York, NYExec · DirectorJonathan Leff · South San Francisco, CADirectorAlthea Stillman · Philadelphia, PAExec · DirectorNader Halim · New York, NYExec · DirectorJonathan Leff · San Francisco, CADirectorAlthea Stillman · Philadelphia, PAExec · DirectorDavid Greenwald · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗